Search Results 671-680 of 1792 for 免费ai写歌网站,ai一键修图网站,ai门户网站,ai工具集官网,ai企业官网,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. Past Lab Members - Mayo Clinic Research

   View past members of Mayo Clinic's Bone Injury and Repair Lab led by Abhishek Chandra, Ph.D., M.S..

2. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

   The purpose of this study is to evaluate the safety and effectiveness of CP101 treatment in adults who had a Clostridum difficile Infection (CDI) recurrence ...

3. Fertility Outcomes in Lymphoma Patients - Mayo Clinic

   About this study. The objectives of this study are to analyze impact of radiation on fertility, to correlate the clinical outcome of fertility after ...

4. A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer - Mayo Clinic

   The main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women with breast ...

5. Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

   About this study. Primary Objective: Phase 1: To determine the maximum tolerated dose (MTD)/maximum administered dose (MAD) of SAR650984 (Isatuximab).

6. Mayo Clinic Doctoral Students Awarded Competitive Career Development Internship to AAAS Workshop - News Archive

   Three doctoral students from Mayo Clinic Graduate School of Biomedical Sciences were awarded the Competitive Career Development Internship.

7. A Study to Provide Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response - Mayo Clinic

   The purpose of this study is to provide personally tailored dietary suggestions to participants based on the Personalized Prediction Engine (patent pending) ...

8. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

   Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

9. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

    An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to ...